Cell counting: Key market research findings
- Growing prevalence of automated hematology instruments
- Increased usage of reagents
Technavio has added a new market research report on the global cell counting market, which is expected to grow at a CAGR of around 8% between 2015 and 2019. Much of this market’s growth is expected to be stimulated by factors like the growing establishment of diagnostic centers in rural areas. The Americas dominate the global market for cell counting, accounting for around 41% of the overall market share. The increasing adoption of automated analyzers by laboratories in the North American region is a critical factor that drives market growth in the Americas during the forecast period.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“The market is witnessing increased usage of automated cell counters to improve the speed and accuracy of cellular blood analysis. These automated hematology instruments use optical light scattering and changes in electrical current. These cell counters are cost-effective as they do not require reagents or dyes. Orflo’s MOXI Z Mini automated cell counter kits produce repeatable cell counts with 95% accuracy in just eight seconds without the use of reagents or dyes,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Technavio market research analysts estimate the reagents segment to account for 80% of the total sales by 2019. Since most diagnostic centers rent equipment and purchase reagents, the sale of reagents is expected to increase steadily during the next four years. The usability of these reagents across a variety of tests is a key factor that drives sales during the forecast period.
The leading vendors in the global cell counting market include BD, Bio-Rad, EMD Millipore and Thermo Fisher Scientific. This market is characterized by the presence of intense competition among several large, medium, and small-sized manufacturers that provide infectious disease diagnostic products. These vendors maintain their hold on the market by providing premium priced products to laboratories and also by forming partnerships with SMEs that enter the market due to its low entry barrier.
A more detailed analysis is available in the Technavio report, Global Cell Counting Market 2015-2019.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
Further Reading:
